1. Rousselot LM, Cole DR, Grossi CE, et al. Intraluminal chemotherapy (HN2 of 5-FU). Adjuvant to operation for cancer of the colon and rectum. Cancer 1967, 20, 829–833.
2. Grossi CE, Wolf WI, Nealon TF, et al. Intraluminal fluorouracil chemotherapy adjuvant to surgical procedure of resectable carcinoma of the colon and rectum. Sur Gyn Obst 1977, 145, 549.
3. Lawrence W, Terz JJ, Horsley S, et al. Chemotherapy as an adjuvant to surgery for colorectal cancer. Ann Surg 1975, 181, 616–623.
4. Dixon WJ, Longmire WP, Holden WD. Use of triethylenethiophosphoramide as an adjuvant to the surgical treatment of gastric and colorectal carcinoma: ten year follow-up. Ann Surg 1971, 173, 26–39.
5. The Veterans Administration Surgical Adjuvant Cancer Chemotherapy Group. Adjuvant use of HN2 (NSC-762). Progress report. Cancer Chemother Rep 1965, 44, 27–30.